
|Videos|January 2, 2018
Exploring the Use of Liquid Biopsies in Smoldering Multiple Myeloma
Author(s)Mark W. Bustoros, MD
Mark W. Bustoros, MD, a postdoctoral fellow at Dana-Farber Cancer Institute, Harvard Medical School, discusses ongoing research exploring the use of liquid biopsies in patients with smoldering multiple myeloma.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer
2
First-in-Human Data Support Izalontamab in Advanced Epithelial Tumors
3
FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma
4
COSMIC-313 Trial: KIM-1 Associated With Clinical Outcomes in Advanced RCC
5









































